Today, Governor JB Pritzker, the Illinois Department of Commerce and Economic Opportunity (DCEO), and Vantive announced that Vantive will invest $23 million and locate its new U.S. headquarters in Deerfield. Vantive, formerly the Kidney Care segment of Baxter International, is a global vital organ therapy company with a 70-year legacy. Today, as a standalone company, Vantive is dedicated to elevating the standards of kidney and vital organ therapies with a vision to enable longer, fuller lives for patients around the world. Today’s announcement builds upon Illinois’ reputation as a global hub for health innovation, biotech, pharmaceuticals and life sciences.
“Illinois is at the center of an innovation ecosystem that will deliver history-altering advancements to the world, and Vantive is a perfect example of that mission,” said Governor JB Pritzker. “As a leader in healthcare innovation, Vantive’s commitment to Illinois will spur more interest and investment – and establish our state as the leader in the vital organ therapy sector. We’re embarking on an ambitious journey to transform healthcare while bringing prosperity to our people in the process.”
With the support of State incentives, Vantive will establish their new U.S. headquarters in Deerfield, following its separation from Baxter in early 2025. This new headquarters will enable the company to expand their office facilities and pharmacy operations, creating at least 50 new full-time jobs. The new U.S. headquarters will give Vantive a significant presence in Illinois allowing the company to remain well-positioned in their mission to extend lives and expand possibilities on behalf of patients and healthcare providers worldwide…